006620 Stock Chart & Stats
₩3640.00
-₩65.00(-1.75%)
―
--
Day’s Range― - ―
52-Week Range₩3,485.00 - ₩6,390.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)95.34K
Market Cap
₩100.19B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)2.0
Beta0.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,464,993
10 Day Avg. Volume90,379
30 Day Avg. Volume95,339
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
006620 FAQ
What was DongKoo Bio & Pharm Co. Ltd.’s price range in the past 12 months?
DongKoo Bio & Pharm Co. Ltd. lowest stock price was ₩3485.00 and its highest was ₩6390.00 in the past 12 months.
What is DongKoo Bio & Pharm Co. Ltd.’s market cap?
DongKoo Bio & Pharm Co. Ltd.’s market cap is ₩100.19B.
When is DongKoo Bio & Pharm Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were DongKoo Bio & Pharm Co. Ltd.’s earnings last quarter?
DongKoo Bio & Pharm Co. Ltd. released its earnings results on May 15, 2026. The company reported -₩21.35 earnings per share for the quarter, missing the consensus estimate of N/A by -₩21.35.
Is DongKoo Bio & Pharm Co. Ltd. overvalued?
According to Wall Street analysts DongKoo Bio & Pharm Co. Ltd.’s price is currently Undervalued.
Does DongKoo Bio & Pharm Co. Ltd. pay dividends?
DongKoo Bio & Pharm Co. Ltd. does not currently pay dividends.
What is DongKoo Bio & Pharm Co. Ltd.’s EPS estimate?
DongKoo Bio & Pharm Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DongKoo Bio & Pharm Co. Ltd. have?
DongKoo Bio & Pharm Co. Ltd. has 28,464,993 shares outstanding.
What happened to DongKoo Bio & Pharm Co. Ltd.’s price movement after its last earnings report?
DongKoo Bio & Pharm Co. Ltd. reported an EPS of -₩21.35 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.34%.
Which hedge fund is a major shareholder of DongKoo Bio & Pharm Co. Ltd.?
Currently, no hedge funds are holding shares in KR:006620
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cell Biotech Co., Ltd
―
MedPacto, Inc.
―
T&R Biofab Co., Ltd
―
ViGenCell, Inc.
―
Vaxcell-Bio Therapeutics
―